Table 4.
Percentage of patients with de novo and hidden migraine in overall and by gender samples.
| Percentage of patients1 | Population | MS-Q questionnaire | Clinical judgment - IHS | Difference |
|---|---|---|---|---|
| Diagnosis de novo2 | Overall sample | 5.7% (5.2% - 6.2%) | 6.1% (5.5% - 6.6%) | 3.1% (-1.1% - +3.7%) |
| Male | 3.4% (2.8% - 4.0%) | 3.7% (3.0% - 4.4%) | 3.3% (-1.2% - +5.9%) |
|
| Female | 7.2% (6.5% - 7.9%) | 7.5% (6.8% - 8.2%) | 3.2% (-1.3% - +6.9%) |
|
| Hidden migraine | Overall sample | 26.6% (24.7% - 28.6%) | 24.1% (21.4% - 29.6%) | 1.4% (-1.4% - +4.2%) |
| Male | 29.4% (24.8% - 33.9%) | 25.5% (21.4% - 29.6%) | 2.9% (-2.3% - +10.0%) |
|
| Female | 26.0% (23.8% - 28.3%) | 23.9% (21.8% - 26.1%) | 2.1% (-1.0% - +5.2%) |
1 Percentages from the number of valid cases were calculated (data not reported in some cases). 2 Statistically significant differences were observed depending on the gender group (p < 0.001; Chi-square test).